pih 1

Upload: joan-luis

Post on 02-Mar-2018

221 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/26/2019 PIH 1

    1/44

  • 7/26/2019 PIH 1

    2/44

    Hypertension in PregnancyHypertension in Pregnancy

    ClassificationClassificationChronic hypertension

    Gestational hypertension (only during pregnancy)

    Preeclampsia Superimposed upon chronichypertension or Renal Disease

    Preeclampsia - eclampsia

    Transient hypertension (only after pregnancy)

  • 7/26/2019 PIH 1

    3/44

    Chronic HypertensionChronic Hypertension

    Defined as hypertension

    diagnosed

    Before pregnancy

    Before the 20th week of gestation

    During pregnancy and not resolvedpostpartum

  • 7/26/2019 PIH 1

    4/44

    Gestational HypertensionGestational Hypertension

    Gestational Hypertension:

    Systolic >140

    Diastolic>90

    No Proteinurea

    25% Develop Preecla!psia

  • 7/26/2019 PIH 1

    5/44

    Gestational HypertensionGestational Hypertension

    Diagnosis of gestational hypertension: Detected for first time after midpregnancy o proteinuria

    !nly until a more specific diagnosis can "e assignedpostpartum

    #f preeclampsia does not de$elop and %P returns to normal "y &' ees postpartum* diagnosis is

    transient hypertension+

    %P remains high postpartum* diagnosis is chronichypertension+

    Proteinurea de$elops Preeclampsiais diagnosed (',incidence)

  • 7/26/2019 PIH 1

    6/44

    Hypertension in PregnancyHypertension in Pregnancy

    "o!plicates #10% o$ prenancies

    #0% Preecla!psiaecla!psia

    &0% "'ronic 'ypertension

    (cla!psia 0)05% inci*ence

    20% o$ +aternal Deat's"ause o$ 10% o$ Preter! ,irt'

    (tioloy un-no.n

  • 7/26/2019 PIH 1

    7/44

    Hypertension in PregnancyHypertension in Pregnancy

    /oun $e!ale & $ol* increase* ris-

    $ricans 2 $ol* increase* ris-

    +ulti$etal prenancies

    .ins

    riplets

    Hypertensionenal Disease

    "ollaen 3ascular Disease

  • 7/26/2019 PIH 1

    8/44

    Blood pressure

    Measure blood pressurein the sitting position, with the

    cuff at the level of the heart. Inferior vena caval

    compression by the gravid uterus while the patient is

    supine can alter readings substantially, leading to an

    underestimation of the blood pressure. Blood pressures

    measured in the left lateral position similarly may yieldfalsely low values if the blood pressure is measured in

    the higher arm and the cuff is not maintained at heart

    level.

    llow women to sit !uietlyfor "#$0 minutes beforemeasuring the blood pressure.

  • 7/26/2019 PIH 1

    9/44

    %ecord &orotkoff soundsI 'the first sound(and I) 'the muffling of sound( to denote thesystolic blood pressure '*+B( and D+B,respectively. In about " of women, an

    e-aggerated gap e-ists between the fourth'muffling( and fifth 'disappearance( &orotkoffsounds, with the fifth sound approaching ero.In this setting, record both the fourth and fifth

    sounds 'eg, $20/0/10 with sound I $20, soundI) 0, sound ) 10(.

  • 7/26/2019 PIH 1

    10/44

  • 7/26/2019 PIH 1

    11/44

    19 years ol* la*y G1 P0 .as seen at t'e antenatal clinic at &2 .ee-s

    estation $or routine c'ec- up) n ea!ination s'e loo-e* enerally

    .ell6 ,loo* pressure .as 150790 pulse 807! .it' lo.er li!, oe*e!a

    ) terus .as appropriate $or *ate .it' a via,le $etus) rine analysis

    s'o.e* protein)

    ; .'at is t'e *ianosis

    ; .'at investiations to per$or!

    ; .'at treat!ent to co!!ence

    19 years ol* la*y G1 P0 .as seen at t'e antenatal clinic at &2 .ee-s

    estation $or routine c'ec- up) n ea!ination s'e loo-e* enerally

    .ell6 ,loo* pressure .as 150795 pulse 807! .it' lo.er li!, oe*e!a

    ) terus .as appropriate $or *ate .it' a via,le $etus) rine analysis

    s'o.e* protein)

    ; .'at is t'e *ianosis

    ; .'at investiations to per$or!

    ; .'at treat!ent to co!!ence

  • 7/26/2019 PIH 1

    12/44

    19 years ol* la*y G1 P0 .as a*!itte* to t'e la,our .or* at &2 .ee-s

    estation co!plainin o$ 'ea*ac'e) n ea!ination s'e loo-e*

    enerally un.ell6 irrita,le6 epiastric pain6 nausea < ,loo* pressure.as 1=07110 pulse 907! .it' lo.er li!, an* a,*o!inal .all oe*e!a

    6 re$lees eaerate*) terus .as s!all $or *ate .it' a via,le

    $etus) rine analysis s'o.e* protein)

    ; .'at is t'e *ianosis

    ; .'at investiations to per$or!

    ; .'at treat!ent to co!!ence

  • 7/26/2019 PIH 1

    13/44

    ?N"?D(N"(: 510% 0$ all prenancies ) 20% recurrence

    'is is t'e t'ir* !ost i!portant cause o$ !aternal !ortality.orl*.i*e

    D(@?N??N @ H/P(A(NS?N:

    D)B)P) > 90 !!H or

    S)B)P) > 140 !!H or

    ise in D)B)P) o$ at least 15 !!H Cp'ysioloical c'anes or

    ise in S)B)P) o$ at least &0 !!H

    P?(N(:

    +roteinurea is defined as urinary e-cretion 0.3 g protein or greater in a 21#hour

    30 mg/dl '4$ or greater on urine dip specimen(

    (D(+: 90% prenancy)proressive

    a,an*one*

    7

  • 7/26/2019 PIH 1

    14/44

    E(nlare* placenta e)FFFF)

    EPreeistin 'ypertension6 renalEPreeistin vascular *isease

    EP0 >>>> !ultip

    E@a!ily 'istory

    ENe. 'us,an*

  • 7/26/2019 PIH 1

    15/44

    E,nor!al trop'o,last invasionF

    $irst 12 .ee-s6 t'e *eci*ual se!ents o$ t'e spiral arteries

    are inva*e*F increase* $lo. to interrvellous spaceF ,y 20

    .ee-s trop'o,last inva*es intra!yo!etrial se!ent o$ spiral

    arteries>>> re*uce resistance to ,loo* $lo. to placenta)C'i'

    volu!e

    ?n P( trop'o,last invasion is patc'y < spiral arteries retain

    t'eir !uscular .allsF) eason

  • 7/26/2019 PIH 1

    16/44

    ENor!al prenancy: !ar-e* perip'eral vaso*ilatationF) 4 $ol* increasein prostacyclin CPG?2 nor!al t'ro!,oane an* increase* nitric oi*e ,y

    vascular en*ot'eliu!

    EPreecla!psia: no c'ane7re*uction in prostacyclin an* N))

    synt'esisFF) 3asospas! an* en*ot'elial cell *ys$unction>>> plateletactivation an* !icro areate $or!ation

    ?t is a !ulti oran a$$ectin *isease7 syn*ro!e

    'e!orr'ae an* necrosis in !any orans66 arteriolar constriction

    -i*neys: lo!erioloen*ot'eliosis

    acute at'erosis o$ spiral arteries6 platelets !icro

    areates

  • 7/26/2019 PIH 1

    17/44

    Pathophysiologic Abnormalities in Preeclampsia

    Generalized vasospasm Activation of coagulation system Abnormal hemostasis Altered thromboxane-prostacyclin ratio Endothelial cell injury

    Abnormal hemodynamics Reduced uteroplacental blood flow

  • 7/26/2019 PIH 1

    18/44

    PathophysiologyPathophysiology

    Heart: Generally unaffected. cardiacdecompensation in the presence of pree/istingheart disease+

    0idney: Renal lesions (glomerularendotheliosis). G1R and renal "lood flodecrease. hyperuricemia. proteinuria may appearlate in clinical course. hypocalciuria. alterations

    in calcium regulatory hormones. impairedsodium e/cretion. suppression of reninangiotensin system+

  • 7/26/2019 PIH 1

    19/44

    PathophysiologyPathophysiology

    Coagulation System: Throm"ocytopenia.lo antithrom"in ###. higher fi"ronectin+

    2i$er: H322P syndrome (hemolysis* ele$ated 42Tand 4ST* and lo platelet count)+

    CS: 3clampsia is the con$ulsi$e phase ofpreeclampsia+ Symptoms may include headache

    and $isual distur"ances* including "lurred $ision*scotomata* and* rarely* cortical "lindness+

  • 7/26/2019 PIH 1

    20/44

    Symptoms of PreeclampsiaSymptoms of Preeclampsia3isual *istur,ances typical o$ preecla!psia are

    scintillations an* scoto!ata) 'ese *istur,ances are

    presu!e* to ,e *ue to cere,ral vasospas!)

    Hea*ac'e is o$ ne. onset an* !ay ,e *escri,e* as

    $rontal6 t'ro,,in6 or si!ilar to a !iraine

    'ea*ac'e) Ho.ever6 no classic 'ea*ac'e o$

    preecla!psia eists)

    (piastric pain is *ue to 'epatic s.ellin an*in$la!!ation6 .it' stretc' o$ t'e liver capsule) Pain

    !ay ,e o$ su**en onset6 it !ay ,e constant6 an* it

    !ay ,e !o*eratetosevere in intensity)

  • 7/26/2019 PIH 1

    21/44

    Symptoms of preeclampsiaSymptoms of preeclampsia

    A'ile !il* lo.er etre!ity e*e!a is co!!on innor!al prenancy6 rapi*ly increasin ornon*epen*ent e*e!a !ay ,e a sinal o$*evelopin preecla!psia) Ho.ever6 t'is sinalt'eory re!ains controversial an* recently 'as ,eenre!ove* $ro! !ost criteria $or t'e *ianosis o$

    preecla!psia)

    api* .ei't ain is a result o$ e*e!a *ue tocapillary lea- as .ell as renal so*iu! an* $lui*retention)

  • 7/26/2019 PIH 1

    22/44

    Physical Findings inPhysical Findings in

    PreeclampsiaPreeclampsiaBloo* Pressure

    Proteinurea

    etinal vasospas! or etinal e*e!a

    i't upper ua*rant C; a,*o!inal

    ten*erness ste!s $ro! liver s.ellin an*

    capsular stretc'

  • 7/26/2019 PIH 1

    23/44

    Physical findings inPhysical findings in

    PreeclampsiaPreeclampsia Bris-6 or 'yperactive6 re$lees are co!!on

    *urin prenancy6 ,ut clonus is a sin o$neuro!uscular irrita,ility t'at raises concern)

    !on prenant .o!en6 &0% 'ave so!elo.er etre!ity e*e!a as part o$ t'eir nor!al

    prenancy) Ho.ever6 a su**en c'ane in

    *epen*ent e*e!a6 e*e!a in non*epen*ent areassuc' as t'e $ace an* 'an*s6 or rapi* .ei't ainsuests a pat'oloic process an* .arrants$urt'er evaluation

  • 7/26/2019 PIH 1

    24/44

    EA'y screenin

    Eccuracy) terine artery *oppler at 24 .ee-s6 notc'in on ,ot'

    uterine arteries i*enti$ies 80% .'o .ill *evelop P(666 5% $alse

    positive

  • 7/26/2019 PIH 1

    25/44

    Maternal

    55 6etal

  • 7/26/2019 PIH 1

    26/44

  • 7/26/2019 PIH 1

    27/44

    Methods Used to Prevent Hypertensive Disorders of Pregnancy

    Proper prenatal care ow-salt diet !iuretics

    Antihypertensive drugs "utritional supplementation

    #agnesium $%&' mg(d) *inc $+, mg(d) alcium $.',,/+,, mg(d)

    0ish oil

    Antithrombotic agents ow-dose aspirin $',/.', mg(d) !ipyridamole $++'/%,, mg(d) 1ubcutaneous heparin $.'2,,, 34(d)

  • 7/26/2019 PIH 1

    28/44

    Low doses of aspirin do help prevent

    pre-eclampsia, but there is littleinformation about whether they are ofbenefit for treatment of established pre-eclampsia cochrane 22 April 2003

    Pre-eclampsia is a condition in pregnancy involving high bloodpressure and protein in the urine5 3t can lead to seriouscomplications and death5 As pre-eclampsia affects blood clotting2antiplatelets $drugs li6e aspirin which can prevent blood clots) areused for pre-eclampsia5 7he review of trials found that low doses

    of aspirin lowered the ris6 of pre-eclampsia a little $.'8 loweringin the ris6)2 with a similar lowering in the ris6 of the baby dying$.98) and a very small lowering in the ris6 of the baby beingborn too early $:8)5 !oses less than ;'mg appear to be safe5

  • 7/26/2019 PIH 1

    29/44

    alcium supplements may prevent high blood

    pressure and help prevent preterm labour!cochrane 22 April 2003

    %eviewers7 conclusions8"alciu! supple!entation appears to ,e ,ene$icial $or .o!en at

    'i' ris- o$ estational 'ypertension an* in co!!unities .it' lo.

    *ietary calciu! inta-e) pti!u! *osae reuires $urt'er

    investiation)

    Main results8

    (leven stu*ies .ere inclu*e*6 all o$ oo* uality) 'ere .as a !o*est

    re*uction in 'i' ,loo* pressure .it' calciu! supple!entation ) 'e e$$ect

    .as reatest $or .o!en at 'i' ris- o$ 'ypertensionCrelative ris- 0)456 95%

    con$i*ence interval 0)&1 to 0)== an* t'ose .it' lo. ,aseline *ietary calciu!

    Crelative ris- 0)496 95% con$i*ence interval 0)&8 to 0)=2)

  • 7/26/2019 PIH 1

    30/44

    9:;;+ *M:

    B%?+@I> +;A:=@:

    +?;M>=%< >:D:M

    A?@: %:=; 6I;?%:A:%:B%; 9:M>%%9:

    )I*?; DI*@?%B=A:* C B;I=D=:**

    9:+@IA %?+@?%:

    :;:A@%>;*@+%@?M A>;;+*:

    S3R#!5S C!6P2#C4T#!S: -

    H/P((NS?N D?NG P(GNN"/

  • 7/26/2019 PIH 1

    31/44

    A?%: / +%:):=@ +%>%:**I>= #

    A;>*: M>=I@>%I=

    %:D?A: B;>>D +%:**?%: #@@%:@# $10/0

    +%>M>@: 6>:@; M@?%I@;>= +%:==A< '31 # 3E F::&*(

    @> A9I:): 6>:@; M@?%I@< @:%MI=@I>=

    D:;I):%BG:A@I):* >6 M=:M:=@

    H/P((NS?N D?NG P(GNN"/

    H/P((NS?N D?NG P(GNN"/

  • 7/26/2019 PIH 1

    32/44

    ;>>& 6>% ++:%=A: >6 >MI=>?*

    6:@?%:*

    DI;%D B.+ 1 @IM:*, M>=I@>%?%I=: >?@+?@ C @:*@ 6>% +%>@:I=?%I

    H?;I. / H?=@

    ;@.DD< F:I9@:):%< 1@9 D?=@, ;.6.@. ';D9(

    F::&;

  • 7/26/2019 PIH 1

    33/44

    DI;< # A;I=IA; 6>:@; M>=I@>%I= #

    69*, 6?=D; 9t. BD>MI=; I%@9,

    ;IH?>%, 6>:@; M>):M:=@ A>?=@, A.@.?* # >= DMI**I>= C @9:= 3 F::&;% 6>:@; BI>+9% )>;?M:D>+;;:% ?* 6>% +;A:=@; B;>>D

    6;>F ):;>AI@< :):%< 1@9 D 6>% M@?%I@ 5F 4C0. S.6.,. H7P.,0./S85/

    0here is no consens$s on the optim$m ac$te treatment&

    0he important o(

  • 7/26/2019 PIH 1

    42/44

    0here is still ins$fficient trial evidence to determine whether the (enefits o$tw

    any disadvantages& 8f it is to (e $sed the s$ggested indications are: -#BP ?@1!! mmHg

    -pregnancy A@=2 wee9s

    fetal and maternal state otherwise good&

    "ethyldopa remains the dr$g of first choice&

    7he combined a- and $B- bloc6ing agent labetalol is commonly used5

    7he potent vasodilator and calcium channel bloc6er nifedipine is a usesecond-line treatment5 3ts major drawbac6 is severe headache5

    Angiotensin-converting enzyme (AC! inhibitors have deleterious fetal effeand their use is not recommended5 3f a woman with chronichypertension becomes pregnant on an AE inhibitor2 change to anotanti-hypertensioe agent is advised5

    >5/.,-0.,3 C5/0,5> 5F S.6.,. H7P.,0./S85/

  • 7/26/2019 PIH 1

    43/44

    77iming of delivery? 7he most common grounds for delivery are>progressive fetal compromise $i5e5 when the baby is safer

    delivered)uunacceptable ris6 to maternal health2 e5g5 uncontrollable BP2impending renal failure or heart failure2

  • 7/26/2019 PIH 1

    44/44

    @he mode of delivery 'caesarean section versus vaginal( depends

    on8

    t'e seriousness o$ t'e situation

    t'e estational ae

    t'e *eree o$ $etal7!aternal co!pro!ise)

    E (pi*ural analesia is t'e !et'o* o$ c'oice $or la,our Cas lonas a

    coaulation *e$ect 'as ,een eclu*e*)

    E ppropriate $acilities $or t'e care o$ t'e ne.,orn availa,le